Fatemeh Amin Selected Research

Gabolysat PC60

2/2013

Neuroprotective consequences of postconditioning on embolic model of cerebral ischemia in rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatemeh Amin Research Topics

Disease

4	Inflammation (Inflammations) 09/2021 - 07/2020
3	Lung Injury 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2022 - 09/2019
2	Stroke (Strokes) 11/2015 - 02/2013
1	Poisoning 10/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Bronchitis 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Cough 01/2021
1	Hypertension (High Blood Pressure) 09/2019
1	Hypercholesterolemia 09/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2015
1	Wounds and Injuries (Trauma) 11/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015
1	Myocardial Infarction 10/2015
1	Embolic Stroke 02/2013
1	Brain Edema (Cerebral Edema) 02/2013
1	Infarction (Infarctions) 02/2013
1	Hyperemia 02/2013

Drug/Important Bio-Agent (IBA)

8	ParaquatIBA 10/2022 - 07/2020
5	Pioglitazone (Actos)FDA Link 01/2022 - 07/2020
5	carvacrolIBA 01/2022 - 07/2020
4	AntioxidantsIBA 01/2021 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2020
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 07/2020
2	HerbicidesIBA 01/2021 - 09/2020
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2022
1	Simvastatin (Zocor)FDA LinkGeneric 10/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	XuebijingIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2022
1	CholesterolIBA 01/2022
1	Coenzyme A (CoA)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	DiureticsIBA 01/2021
1	OvalbuminIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Anti-Allergic Agents (Antiallergic Agents)IBA 09/2019
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 09/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2015
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2015
1	Peptides (Polypeptides)IBA 10/2015
1	cytochrome b245IBA 10/2015
1	Superoxides (Superoxide)IBA 10/2015
1	Gabolysat PC60IBA 02/2013
1	N 30IBA 02/2013
1	salicylhydroxamic acid (SHAM)IBA 02/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013

Therapy/Procedure

1	Nebulizers and Vaporizers (Inhaler) 10/2022
1	Persian Medicine 09/2019
1	Treatment Delay 11/2015
1	Therapeutics 11/2015
1	Ischemic Postconditioning 02/2013